Le Lézard
Classified in: Health, Science and technology
Subjects: MISCELLANEOUS, MISCELLANEOUS

Publication Relating to Transparency Notifications


                

 REGULATED INFOMATION

Publication Relating to Transparency Notifications

Mont-Saint-Guibert (Belgium), April 20, 2023, 10.30pm CET / 4.30pm ET ? In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below.

Together Partnership

On April 18, 2023, Nyxoah received a transparency notification from Together Partnership following the crossing of the 10% threshold by Together Partnership on March 30, 2023. As of such date, Together Partnership held 2,948,285 shares, representing 10.42% of the total number of voting rights on March 30, 2023 (28,286,985).

The notification dated April 17, 2023 contains the following information:

A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the
securities
Linked to securitiesNot linked to the
securities
Together Partnership2,503,5002,948,285   10.42% 
 TOTAL2,948,285 0 10.42%0.00%

 ResMed Inc.

On April 18, 2023, Nyxoah received a transparency notification from ResMed Inc. following the crossing of the 5% threshold by ResMed Inc. on March 30, 2023. As of such date, ResMed Inc. held 1,499,756 shares, representing 5.30% of the total number of voting rights on March 30, 2023 (28,286,985).

The notification dated April 16, 2023 contains the following information:

A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the
securities
Linked to securitiesNot linked to the
securities
ResMed Inc.794,235 1,499,756   
 TOTAL1,499,756 05.30%0.00%

*

* *

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
[email protected]
+1 310 310 1313


Attachment



These press releases may also interest you

at 17:50
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...



News published on and distributed by: